At last, good news, indeed great news. I wonder what happens now, are the bean counters in Eli Lilly up at night crunching figures, or is someone else. Whatever,ACR are now in the driving seat, with Axiron gaining market share in the U.S., product release getting closer for Axiron in a couple of markets at least, Canada and Aust, from memory, don't know what's happening in Europe anyone have any info on this. In my view Acrux is beginning to look like an inviting apple for someone to pluck.
ACR Price at posting:
$3.89 Sentiment: Buy Disclosure: Held
